Immunology

Researchers ready B cells for novel cell therapy

Scientists at Seattle Children's Research Institute are paving the way to use gene-edited B cells—a type of white blood cell in the immune system—to treat a wide range of potential diseases that affect children, including ...

Cardiology

A protein enables cardiovascular risk assessment

Researchers at the Charité – Universitätsmedizin Berlin have managed to predict the probability of a cardiovascular patient suffering a heart attack, stroke or arterial occlusion within three months. In the long-term, ...

Cardiology

Potential novel biomarkers of coronary heart disease discovered

Coronary heart disease (CHD) is one of the most common causes of death worldwide—especially in Europe: Here, it is responsible for nearly half of all deaths. Among middle-aged adults, individuals with type 2 diabetes (T2D) ...

Medications

Ruconest approved for rare genetic disease

(HealthDay)—Ruconest has been approved by the U.S. Food and Drug Administration to treat hereditary angioedema, a genetic disease that leads to sudden and potentially fatal swelling of the hands, feet, limbs, face, intestinal ...

page 10 from 12